Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Molecular Cancer Therapeutics|November 8, 2019
CRISPR Screening Identifies WEE1 as a Combination Target for Standard Chemotherapy in Malignant Pleural MesotheliomaDuo Xu, Shun-Qing Liang, Haitang Yang, et al.Cancers|October 11, 2019
Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural MesotheliomaDuo Xu, Haitang Yang, Zhang Yang, et al.Clinical and Translational Medicine|September 30, 2025
Distinct molecular subtypes of KRASG12C-mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategiesHaitang Yang, Anshun Zhu, Yongliang Niu, et al.British Journal of Cancer|June 21, 2018
Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesotheliomaDuo Xu, Shun-Qing Liang, Haitang Yang, et al.Ebiomedicine|November 5, 2021
Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancerLimei Wang, Haitang Yang, Patrick Dorn, et al.Translational Lung Cancer Research|May 20, 2021
Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinomaTuo Zhang, Beibei Sun, Chenxi Zhong, et al.Lung Cancer (Amsterdam, Netherlands)|October 9, 2024
Crispr-mediated genome editing reveals a preponderance of non-oncogene addictions as targetable vulnerabilities in pleural mesotheliomaDuo Xu, Shun-Qing Liang, Min Su, et al.EMBO Molecular Medicine|July 24, 2025
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesotheliomaDuo Xu, Yanyun Gao, Shengchen Liu, et al.Nature Communications|March 17, 2025
Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancerHaibin Deng, Liang Zhao, Huixiang Ge, et al.Journal of Experimental & Clinical Cancer Research : CR|January 18, 2022
Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancerZhang Yang, Shun-Qing Liang, Liang Zhao, et al.Pageof 7